Categories rss rss-es rss-pt ZINBRYTA (daclizumab beta)- Voluntary Withdrawal in Canada due to Risk of EncephalitisMurilo Freitas - 04:00, 15 de marzo de 2018675 0 http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/66214a-eng.php 0
